Article Listing - Altana and Atugen renew target validation accord

ELI LILLY: DES SETTLEMENT

25 May 1992

- Eli Lilly has arrived at an out- of-court settlement with a New York woman, whose mother had taken the...

KYOWA HAKKO KOGYO: R&D PROJECTS

25 May 1992

- Kyowa Hakko Kogyo is to start autumn clinical studies on the carcinostatic Duocarmicin (kw-2189), its solid tumor treatment. The...

ALBERTA RESEARCH COUNCIL DEAL WITH GLYCOMED

25 May 1992

- The Alberta Research Council has signed a $10 million R&D contract with Glycomed Inc, a US firm. This partnership...

ASTRA'S PLENDIL HEADING FOR CHF INDICATION

25 May 1992

Currently approved for use as an antihypertensive, Astra's third generation dihydropyridine vasoselective calcium channel blocker Plendil (felodipine) may also represent...

ASTRA TO FUND CMV TREATMENT STUDY

25 May 1992

Astra is to fund a comparative study of its Foscavir (foscarnet) and Syntex' Cytovene/Cymevene (ganciclovir) to determine which therapy is...

SUPPORTIVE CARE DRUGS IN CANCER: ASCO DATA

25 May 1992

A number of compounds aimed at protecting cancer patients from the side effects of aggressive cytotoxic chemotherapy and improving the...

UK LAUNCH OF MERIEUX' TYPHIM Vi

25 May 1992

Announcing the forthcoming UK launch of the first single dose typhoid fever vaccine, Merieux UK Ltd has expressed confidence that...

JAPANESE DRUGMAKERS SET SALES AIMS

25 May 1992

A number of Japanese pharmaceutical companies are looking to good growth in the coming years, and are setting ambitious sales...

EC PARLIAMENT VOTES FOR DRUG PATENT EXTENSION

25 May 1992

The European Parliament approved the Merz report on the supplementary protection certificates for medicines at its plenary session in Stras-bourg...

"LARGER STEPS" WARNING TO INDIA ON PATENTS

25 May 1992

The shock decision by the US government to deprive Indian pharmaceutical and chemical exports to the USA of duty benefits...

Showing 94041-94050 of 95569 articles